This page shows results related to Alaway and Lacrimation Increased from the FDA Adverse Event Reporting System (AERS). The adverse event Lacrimation Increased has been reported to the FDA a total of 22 times for Alaway.
Learn More About Alaway Adverse EventsThe Proportional Reporting Ratio (PRR) for Alaway and Lacrimation Increased is 76. The chart below compares this proportional reporting ratio of Lacrimation Increased for drugs used in similar therapies to Alaway. The higher the proportional reporting ratio is, the more likely a drug is associated with Lacrimation Increased.
| Lacrimation Increased | |
| Alaway | 50 |
NOTE: The PRR metric is still in Beta testing by DrugCite and is intended for use by researchers only.
Of those reporting Lacrimation Increased, why were they taking Alaway?
| Eye Pruritus | 10 |
| Lacrimation Increased | 4 |
| Eye Irritation | 3 |
| Eye Allergy | 3 |
| Eyelids Pruritus | 1 |
| Seasonal Allergy | 1 |
 Show More |
Which medications reported to the FDA are most commonly associated with Lacrimation Increased?
| Enbrel | 205 |
| Restasis | 192 |
| Zometa | 160 |
| Humira | 143 |
| Gleevec | 111 |
| Xalatan | 101 |
| Lyrica | 80 |
| Spiriva | 79 |
| Aredia | 78 |
| Vioxx | 66 |
| Remicade | 60 |
| Show More |
